Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision tag on the site changed from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T20:13:29.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added the long-form study title for Pembrolizumab in HBV-related hepatocellular carcinoma and later removed an alternate title variant, with related regulatory notes.
    Difference
    0.6%
    Check dated 2026-03-05T17:59:45.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now active, replacing v3.4.1. This update does not appear to change the study details or other critical information.
    Difference
    0.1%
    Check dated 2026-02-12T01:45:39.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 indicates a minor platform release. No observable changes to study content or user-facing features were detected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:54:20.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A glossary toggle was added. QC/FEAR-related labels and revision information were updated, introducing 'Revision: v3.4.0' and removing the previous labels.
    Difference
    0.3%
    Check dated 2026-01-28T18:41:57.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 revision on the page. This appears to be a minor version update with no substantive changes to study content.
    Difference
    0.1%
    Check dated 2026-01-14T03:48:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.